Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Galα1,3Gal epitope

Transplantation

Volumn 63, Issue 11, 1997, Pages 1673-1682

  Liu, Jining ^a   Qian, Yunjian ^a   Holgersson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GALACTOSYLTRANSFERASE; GLYCOPROTEIN; HETEROPHILE ANTIBODY; HETEROPHILE ANTIGEN; MUCIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOADSORPTION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ABSORPTION; ANIMALS; ANTIBODIES; ANTIBODY AFFINITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; COS CELLS; DISACCHARIDES; EPITOPES; GALACTOSE; GLYCOPROTEINS; GRAFT REJECTION; HUMANS; IMMUNOSORBENT TECHNIQUES; MUCINS; RECOMBINANT PROTEINS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030916762     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706150-00023     Document Type: Article

References (64)

1. Dorling A, Lechler RI. Prospects for xenografting. Curr Opin Immunol 1994; 6(5): 765.
2. Ye Y, Niekrasz M, Kosanke S, et al. The pig as a potential organ donor for man: a study of potentially transferable disease from donor pig to recipient man. Transplantation 1994; 57(5): 694.
3. Michaels MG, Simmons RL. Xenotransplant-associated zoonoses: strategies for prevention. Transplantation 1994; 57(1): 1.
4. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2(4): 550.
5. Bach FH, Robson SC, Ferran C, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141: 5.
6. Magee JC, Platt JL. Xenograft rejection: molecular mechanisms and therapeutic implications. Ther Immunol 1994; 1(1): 45.
7. Platt JL, Lindman BJ, Chen H, Spitalnik SL, Bach FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50(5): 817.
8. Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24(2): 559.
9. Holgersson J, Cairns TD, Karlsson EC, et al. Carbohydrate specificity of human immunoglobulin-M antibodies with pig lymphocytotoxic activity. Transplant Proc 1992; 24(2): 605.
10. Oriol R, Ye Y, Koren E, Cooper DK. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56(6): 1433.
11. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14(10): 480.
12. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90(23): 11391.
13. Cairns TD, Taube DH, Stevens N, Binns R, Welsh KI. Xenografts: future prospects for clinical transplantation. Immunol Lett 1991; 29(1-2): 167.
14. Rydberg L, Hallberg E, Björck S, et al. Studies on the removal of anti-pig xenoantibodies in the human by plasmapheresis/immunoadsorption. Xenotransplantation 1995; 2: 253.
15. Soares MP, Latinne D, Elsen M, Figueroa J, Bach FH, Bazin H. In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody. Transplantation 1993; 56(6): 1427.
16. Soares M, Lu X, Havaux X, et al. In vivo IgM depletion by anti-mu monoclonal antibody therapy: the role of IgM in hyperacute vascular rejection of discordant xenografts. Transplantation 1994; 57(7): 1003.
17. Leventhal JR, John R, Fryer JP, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption: results of in vitro and in vivo studies. Transplantation 1995; 59(2): 294.
18. Geller RL, Bach FH, Turman MA, Casali P, Platt JL. Evidence that polyreactive antibodies are deposited in rejected discordant xenografts. Transplantation 1993; 55(1): 168.
19. Koren E, Milotic F, Neethling FA, et al. Murine monoclonal anti-idiotypic antibodies directed against human anti-alpha Gal antibodies prevent rejection of pig cells in culture: implications for pig-to-human organ xenotransplantation. Transplant Proc 1996; 28(2): 559.
20. Leventhal JR, Sakiyalak P, Witson J, et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1994; 57: 974.
21. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57(3): 363.
22. Neethling FA, Koren E, Oriol R, et al. Immunoadsorption of natural antibodies from human serum by affinity chromatography using specific carbohydrates protects pig cells from cytotoxic destruction. Transplant Proc 1994; 26(3): 1378.
23. Neethling FA, Koren E, Ye Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by alpha-galactosyl oligosaccharides. Transplantation 1994; 57(6): 959.
24. Li S, Yeh J-C, Cooper DKC, Cummings RD. Inhibition of human anti-aGal IgG by oligosaccharides derived from porcine stomach mucin. Xenotransplantation 1995; 2: 279.
25. Cooper DK, Good AH, Ye Y, et al. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. Transplant Proc 1993; 25(1 Pt 1): 377.
26. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1995; 1(12): 1261.
27. Sharma A, Okabe J, Birch P, et al. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93(14): 7190.
28. Koike C, Kannagi R, Takuma Y, et al. Introduction of a(1,2)-fucosyltransferase and its effect on a-Gal epitopes in transgenic pig. Xenotransplantation 1996; 3: 81.
29. Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58(10): 1059.
30. Seebach JD, Yamada K, McMorrow IM, Sachs DH, DerSimonian HD. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996; 3: 188.
31. Chou DK, Dodd J, Jessell TM, Costello CE, Jungalwala FB. Identification of alpha-galactose (alpha-fucose)-asialo-GM1 glycolipid expressed by subsets of rat dorsal root ganglion neurons. J Biol Chem 1989; 264(6): 3409.
32. Fujiwara S, Shinkai H, Deutzmann R, Paulsson M, Timpl R. Structure and distribution of N-linked oligosaccharide chains on various domains of mouse tumour laminin. Biochem J 1988; 252(2): 453.
33. Dasgupta S, Hogan EL, Glushka J, van Halbeek H. Branched monosialo gangliosides of the lacto-series isolated from bovine erythrocytes: characterization of a novel ganglioside, NeuGc-isooctaosylceramide. Arch Biochem Biophys 1994; 310(2): 373.
34. Wong CH. Enzymatic and chemo-enzymatic synthesis of carbohydrates. Pure Appl Chem 1995; 67(10): 1609.
35. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 1987; 329(6142): 840.
36. Khodadoust MM, Candal FJ, Maher SE, et al. PEC-A: an immortalized porcine aortic endothelial cell. Xenotransplantation 1995; 2: 79.
37. Dabkowski PL, Vaughan HA, McKenzie IF, Sandrin MS. Characterisation of a cDNA clone encoding the pig alpha 1,3 galactosyltransferase: implications for Xenotransplantation. Transplant Proc 1993; 25(5): 2921.
38. Dabkowski PL, Vaughan HA, McKenzie IF, Sandrin MS. Isolation of a cDNA clone encoding the pig alpha 1,3 galactosyltransferase. Transplant Proc 1994; 26(3): 1335.
39. Gustafsson K, Strahan K, Preece A. Alpha 1,3 Galactosyltransferase: a target for in vivo genetic manipulation in xenotransplantation. Immunol Rev 1994; 141: 59.
40. Sako D, Chang XJ, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75(6): 1179.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227(259): 680.
42. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76(9): 4350.
43. Carraway KL, Hull SR. Cell surface mucin-type glycoproteins and mucin-like domains. Glycobiology 1991; 1(2): 131.
44. Shimizu Y, Shaw S. Mucins in the mainstream. Nature 1993; 366: 630.
45. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-a-galactosyl IgG: II. The specific recognition of a(1-3)-linked galactose residues. J Exp Med 1985; 162: 573.
46. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52(2): 214.
47. Cooper DK, Ye Y, Niekrasz M, et al. Specific intravenous carbohydrate therapy: a new concept in inhibiting antibody-mediated rejection - experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 1993; 56(4): 769.
48. Romano EL, Soyano A, Linares J. Preliminary human study of synthetic trisaccharide representing blood substance A. Transplant Proc 1987; 19(6): 4475.
49. Ye Y, Neethling FA, Niekrasz M, et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58(3): 330.
50. Vaughan HA, Oldenburg KR, Gallop MA, Atkin JD, McKenzie IFC, Sandrin MS. Recognition of an octapeptide sequence by multiple Gala(1,3)Gal-binding proteins. Xenotransplantation 1996; 3: 18.
51. Kooyman DL, McClellan SB, Parker W, et al. Identification and characterization of a galactosyl peptide mimetic: implications for use in removing xenoreactive anti-a Gal antibodies. Transplantation 1996; 61(6): 851.
52. Koren E, Milotic F, Neethling FA, et al. Monoclonal anti-idiotypic antibodies neutralize cytotoxic effects of anti-aGal antibodies. Transplantation 1996; 62: 837.
53. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91(23): 11153.
54. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs: a potential approach for preventing xenograft rejection. Transplantation 1995; 59(9): 1325.
55. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61(8): 1241.
56. Kroshus TJ, Bolman RM III, Dalmasso AP, et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61(10): 1513.
57. Pascher A, Poehlein CH, Storck M, et al. Human decay accelerating factor expressed on endothelial cells of transgenic pigs affects complement activation in an ex vivo liver perfusion model. Transplant Proc 1996; 28(2): 754.
58. Tolan MJ, Friend PJ, Cozzi E, et al. Life-supporting transgenic kidney transplants in a pig-to-primate model. Proceedings of the XVI International Congress of the Transplantation Society, Barcelona, 1996: 102.
59. Schmoeckel M, Nollert G, Shahmohammadi M, et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 1996; 62(6): 729.
60. Rosen SD, Bertozzi CR. Leukocyte adhesion: two selectins converge on sulphate. Curr Biol 1996; 6(3): 261.
61. Asa D, Raycroft L, Ma L, et al. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins. J Biol Chem 1995; 270(19): 11662.
62. Schaapherder AF, Gooszen HG, te Bulte MT, Daha MR. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation 1995; 60(3): 287.
63. Gauldi J, Richards C, Lamontagne L. Fc receptors for IgA and other immunoglobulins on resident and activated alveolar macrophages. Mol Immunol 1983; 20: 1029.
64. Monteiro RC, Kubagawa H, Cooper M. Cellular distribution, regulation, and biochemical nature of an Fca receptor in humans. J Exp Med 1990; 171: 597.